SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹481 Cr | ₹415 Cr | ₹389 Cr | ₹336 Cr | ₹268 Cr |
What is the latest Total Liabilities ratio of SAKAR HEALTHCARE ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹481 Cr |
| Mar2025 | ₹415 Cr |
| Mar2024 | ₹389 Cr |
| Mar2023 | ₹336 Cr |
| Mar2022 | ₹268 Cr |
How is Total Liabilities of SAKAR HEALTHCARE Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹481 Cr | 15.83 | |
| Mar2025 | ₹415 Cr | 6.84 | |
| Mar2024 | ₹389 Cr | 15.56 | |
| Mar2023 | ₹336 Cr | 25.61 | |
| Mar2022 | ₹268 Cr | - | |
Compare Total Liabilities of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹2,097.5 Cr | -2.7% | -15.8% | 165.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | -2.7% |
-15.8% |
165.6% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses